Company
LON:ETX
e-Therapeutics PLC is integrating computational power and biology to accelerate the discovery of life-transforming RNAi medicines. The company has developed and validated a powerful computational approach to drug discovery, leveraging our industry-leading expertise in network biology to fully capture and interrogate human disease complexity. e-Therapeutics' multi-disciplinary team builds computational models of biological functions to transform the search for new medicines, interventions, mechanisms and genetic support.
153 stories · page 7 of 8
Graphene NanoChem receives an order for its oilfield recovery additive, e-Therapeutics tells investors that it remains well funded and Forbidden Technology partners with an energy drink.
The firm is well funded, with a last reported cash balance of £24.8mln.
Versarien pairs with winter Olympian, Ten Alps wins a Bafta and Antonio Banderas to star in SyndicateRoom's film.
Searchbolt, the business being bought, was spun-off from ETX when the latter was listed on stock market in 2007
e-Therapeutics is now targeting partners to accelerate the development of its drug discovery engine and commercialise compounds.
Junior oil stocks were in favour on Tuesday and small cap indices were ahead of Footsie.
It was a mixed start for London's junior market but revolutionary laundry system developer Xeros has scrubbed up very well
e-Therapeutics plc is targeting partners to accelerate the development of its drug discovery engine, it told investors.
Archive
Everything appears to being going to plan for 88 Energy in Alaska...
A tremendous boost for Premier African Minerals, the operator and 49% stakeholder in the RHA tungsten project, which has had a financing offer from local financial institution.
The side effects and tolerance profile of ETS6103 were found to be more benign than amitriptyline.
Investments and investor services
African Potash, e-Therapeutics and sound Energy also reported on Wednesday
Professor Malcolm Young is stepping down as chairman but will remain in his role as chief executive.
Investments and investor services
Fastjet, Ortac Resourves and Genel Energy also had news out...
Archive
The end of quarter is approaching so companies were rushing out end-June trading updates, leading to a very heavy news day.
E-Therapeutics ended its latest half year with cash of more than £30mln.
Investments and investor services
Wolseley and Boohoo.com lead the companies reporting on Tuesday...
Archive
Sainsbury is likely to report continued hard times for the grocers.
The management from eg Solutions, e-Therapeutics, Motif Bio & Amphion Innovations will be updating investors on current developments and future prospects .
The management from e-Therapeutics (LON:ETX), Ergomed (LON:ERGO), Tissue Regenix (LON:TRX) and TekCapital (LON:TEK) will be updating investors on current developments and future prospects.
